Erich Mohr's Net Worth
$2.33 Million
Who is Erich Mohr?
Erich Mohr has an estimated net worth of $2.33 Million. This is based on reported shares across multiple companies, which include PRA International, DelMar Pharmaceuticals, Inc., and Brooklyn ImmunoTherapeutics, Inc..
SEC CIK
Erich Mohr's CIK is 0001298170
Past Insider Trading and Trends
2017 was Erich Mohr's most active year for acquiring shares with 7 total transactions. Erich Mohr's most active month to acquire stocks was the month of November. 2005 was Erich Mohr's most active year for disposing of shares, totalling 3 transactions. Erich Mohr's most active month to dispose stocks was the month of November. 2005 saw Erich Mohr paying a total of $276,875.00 for 18,500 shares, this is the most they've acquired in one year. In 2005 Erich Mohr cashed out on 68,500 shares for a total of $1,425,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PRA International No price found
EVP and Chief Scientific Off.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.67% | 18.5K |
$14.97 | $276,875.00 | 344.91K |
Dec 19
| |||
Form 4
| -15.32% | -50.00K |
$28.50 | -$1,425,000.00 | 276.41K |
Dec 2
| |||
Form 4
| -53.86% | -168.90K |
$23.50 | -$3,969,150.00 | 144.71K |
Jun 20
| |||
Form 4
| -16.27% | -124.36K |
$19.00 | -$2,362,783.00 | 640.02K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DelMar Pharmaceuticals, Inc. (KTRA) Snapshot price: $0.1775
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.86% | 528 |
$3.20 | $1,689.60 | 8.22K |
Mar 30
| |||
Form 4
| +7.37% | 528 |
$3.20 | $1,689.60 | 7.69K |
Dec 31
| |||
Form 4
| +7.95% | 528 |
$3.20 | $1,689.60 | 7.17K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
| +8.64% | 528 |
$3.20 | $1,689.60 | 6.64K |
Jun 30
| |||
Form 4
| +214.46% | 4.17K |
$3.60 | $15,001.20 | 6.11K |
Jun 26
| |||
Form 4
| +37.31% | 528 |
$3.20 | $1,689.60 | 1.94K |
Mar 31
| |||
Form 4
| +59.53% | 528 |
$3.20 | $1,689.60 | 1.42K |
Dec 31
| |||
Form 4
| +147.08% | 528 |
$3.20 | $1,689.60 | 887 |
Oct 3
| |||
Form 4
|
∞
| 359 |
$3.20 | $1,148.80 | 359 |
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Brooklyn ImmunoTherapeutics, Inc. (ERNA) Snapshot price: $1.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||